Drug Updates

Octapharma puts a spotlight on the challenges of managing inhibitors in haemophilia A at the 15th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)

The virtual symposium held on Wednesday, February 2, 2022, at 18:00 CET, will tell the story of the Rodriguez family and their two sons with haemophilia A as they navigate the challenges of inhibitor management. The development of inhibitors to replacement factor VIII (FVIII) therapy continues to be a significant concern for people with haemophilia A and […]

Drug Updates

New Research Finds Challenges in Symptom Recognition and Diagnostic Testing can impact Patient Satisfaction for People with Vascular Disease

Abbott today released new global market research from its Beyond Intervention initiative, the company’s multi-year global research program designed to examine the vascular patient experience from the perspectives of patients, physicians and healthcare leaders. The latest research focuses on challenges that arise for physicians and patients during the earliest stages of the patient journey, uncovering […]

Pandemic Pulse

Copan, putting Covid-19 challenges behind and setting up for the post-pandemic scenario

With an email to the main distributors, Copan group’s CEO describes how the ramp-up of Covid-19-related products has been concluded, and how the company is now reorganizing to face post-pandemic challenges. Last Tuesday, Copan partners received an email signed by Copan’s CEO Stefania Triva herself. Certainly, it was not the first email they received from the leader […]